543207 — Natural Biocon (India) Cashflow Statement
0.000.00%
- IN₹291.86m
- IN₹286.15m
- IN₹135.34m
- 46
- 24
- 58
- 37
Annual cashflow statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.317 | 0.037 | 0.879 | 2.47 | 2.25 |
Depreciation | |||||
Non-Cash Items | — | — | — | 0 | 0 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.84 | 3.21 | 1.06 | -0.366 | -3.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.53 | 3.24 | 1.94 | 2.1 | -1.25 |
Capital Expenditures | 0 | — | 0 | 0 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | 0 | 0 | 0 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Cash from Investing Activities | 0 | — | 0 | 0 | 0 |
Financing Cash Flow Items | 0 | — | 0 | 0 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.44 | -3.22 | -1.54 | -0.186 | -0.885 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.08 | 0.025 | 0.398 | 1.92 | -2.13 |